We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why UnitedHealth Group (UNH) Outpaced the Stock Market Today
Read MoreHide Full Article
UnitedHealth Group (UNH - Free Report) ended the recent trading session at $277.26, demonstrating a +1.2% change from the preceding day's closing price. This move outpaced the S&P 500's daily gain of 0.11%. Meanwhile, the Dow lost 0.13%, and the Nasdaq, a tech-heavy index, added 0.18%.
Shares of the largest U.S. health insurer have depreciated by 6.16% over the course of the past month, outperforming the Medical sector's loss of 6.43%, and lagging the S&P 500's loss of 4.28%.
Investors will be eagerly watching for the performance of UnitedHealth Group in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on April 21, 2026. The company is predicted to post an EPS of $6.46, indicating a 10.28% decline compared to the equivalent quarter last year. Simultaneously, our latest consensus estimate expects the revenue to be $109.95 billion, showing a 0.34% escalation compared to the year-ago quarter.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $17.66 per share and revenue of $440.36 billion. These totals would mark changes of +8.01% and -1.61%, respectively, from last year.
Investors should also take note of any recent adjustments to analyst estimates for UnitedHealth Group. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.24% lower. UnitedHealth Group is holding a Zacks Rank of #3 (Hold) right now.
Investors should also note UnitedHealth Group's current valuation metrics, including its Forward P/E ratio of 15.52. This expresses no noticeable deviation compared to the average Forward P/E of 15.52 of its industry.
We can also see that UNH currently has a PEG ratio of 1.26. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Medical - HMOs industry currently had an average PEG ratio of 0.94 as of yesterday's close.
The Medical - HMOs industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 224, positioning it in the bottom 9% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Why UnitedHealth Group (UNH) Outpaced the Stock Market Today
UnitedHealth Group (UNH - Free Report) ended the recent trading session at $277.26, demonstrating a +1.2% change from the preceding day's closing price. This move outpaced the S&P 500's daily gain of 0.11%. Meanwhile, the Dow lost 0.13%, and the Nasdaq, a tech-heavy index, added 0.18%.
Shares of the largest U.S. health insurer have depreciated by 6.16% over the course of the past month, outperforming the Medical sector's loss of 6.43%, and lagging the S&P 500's loss of 4.28%.
Investors will be eagerly watching for the performance of UnitedHealth Group in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on April 21, 2026. The company is predicted to post an EPS of $6.46, indicating a 10.28% decline compared to the equivalent quarter last year. Simultaneously, our latest consensus estimate expects the revenue to be $109.95 billion, showing a 0.34% escalation compared to the year-ago quarter.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $17.66 per share and revenue of $440.36 billion. These totals would mark changes of +8.01% and -1.61%, respectively, from last year.
Investors should also take note of any recent adjustments to analyst estimates for UnitedHealth Group. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.24% lower. UnitedHealth Group is holding a Zacks Rank of #3 (Hold) right now.
Investors should also note UnitedHealth Group's current valuation metrics, including its Forward P/E ratio of 15.52. This expresses no noticeable deviation compared to the average Forward P/E of 15.52 of its industry.
We can also see that UNH currently has a PEG ratio of 1.26. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Medical - HMOs industry currently had an average PEG ratio of 0.94 as of yesterday's close.
The Medical - HMOs industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 224, positioning it in the bottom 9% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.